Leerink Partners Initiates Coverage On Neurogene with Outperform Rating, Announces Price Target of $46

Neurogene, Inc. - Common Stock -3.08% Post

Neurogene, Inc. - Common Stock

NGNE

44.34

44.34

-3.08%

0.00% Post

Leerink Partners analyst Mani Foroohar initiates coverage on Neurogene (NASDAQ: NGNE) with a Outperform rating and announces Price Target of $46.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via